|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 3/11/10 Nymox Pharmaceutical Corp 20-F 12/31/09 5:1.0M e3 Fil… Computershare/FA |
Document/Exhibit Description Pages Size
1: 20-F Annual Report for the Fiscal Year Ended December HTML 825K
31, 2009
2: EX-12.A Sox Section 302 CEO Certification HTML 12K
3: EX-12.B Sox Section 302 CFO Certification HTML 12K
4: EX-13.A Sox Section 906 CEO Certification HTML 6K
5: EX-13.B Sox Section 906 CFO Certification HTML 6K
| Exhibit 13.b |
Exhibit 13.b
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Roy Wolvin, CFO of Nymox Pharmaceutical Corporation, do hereby certify that, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the information contained in the Annual Report for the year ended December 31, 2009 of Nymox Pharmaceutical Corporation and filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations on Nymox Pharmaceutical Corporation
Date: March 11, 2010
/s/ Roy Wolvin
Roy Wolvin
Chief Financial Officer
Nymox Pharmaceutical Corporation
| This ‘20-F’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/11/10 | 6-K | ||
| For Period End: | 12/31/09 | 6-K | ||
| List all Filings | ||||